gms | German Medical Science

The ABC Conference: Algae Bioactive Compounds – from research to innovation

The project is funded by Interreg Deutschland-Danmark with means from the European Regional Development Fund.

25. - 26.08.2020, Kiel, Germany (online conference)

Fucoidan in future applications – an industrial perspective

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Trond Helgerud - DuPont Nutrition & Bioscience at DuPont, Billingstad, Netherlands

The FucoSan consortium. The ABC Conference: Algae Bioactive Compounds – from research to innovation. Kiel, 25.-26.08.2020. Düsseldorf: German Medical Science GMS Publishing House; 2020. Doc20fucosan10

doi: 10.3205/20fucosan10, urn:nbn:de:0183-20fucosan104

Veröffentlicht: 7. Oktober 2020

© 2020 Helgerud.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe



Fucoidan is a sulphated biopolymer present in brown seaweeds and some other marine organisms. Current commercial fucoidan grades are derived from brown seaweeds, and their structure is dependent on seaweed source. The importance of structure will depend on type of application. With applications potentially ranging from entirely physical to complex bioactivity it will be important to focus on detailed structural characterization. Structural differentiation represents both an opportunity and a challenge, since commercial products require certainty of supply, meaning fucoidan for industrial applications will require access to more than one source and fucoidan needs to be of consistent quality. Focus on reliable and preferably simple analytical tools and methods, will be required to support development of a fucoidan market. This is just one of several aspects related to broader commercial use of fucoidans, and this presentation will focus on how fucoidan can be brought from the stage of being an interesting molecule to a real ingredient in products on the market.